{
    "Symbol": "SBFM",
    "AssetType": "Common Stock",
    "Name": "Sunshine Biopharma Inc",
    "Description": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.",
    "CIK": "1402328",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, POINTE-CLAIRE, QC, CA",
    "OfficialSite": "https://sunshinebiopharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5360500",
    "EBITDA": "-4761139",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "12.52",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-127.9",
    "RevenuePerShareTTM": "197.42",
    "ProfitMargin": "-0.128",
    "OperatingMarginTTM": "-0.131",
    "ReturnOnAssetsTTM": "-0.107",
    "ReturnOnEquityTTM": "-0.18",
    "RevenueTTM": "32959500",
    "GrossProfitTTM": "10144800",
    "DilutedEPSTTM": "-127.9",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.416",
    "AnalystTargetPrice": "300",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.171",
    "PriceToBookRatio": "0.225",
    "EVToRevenue": "39.48",
    "EVToEBITDA": "-7.73",
    "Beta": "-1.477",
    "52WeekHigh": "248",
    "52WeekLow": "1.9",
    "50DayMovingAverage": "2.417",
    "200DayMovingAverage": "3.474",
    "SharesOutstanding": "2708300",
    "DividendDate": "2020-04-06",
    "ExDividendDate": "None"
}